ResMed Shares Plunge 1.05% as 349th in Trading Volume Amid Healthcare Policy Fears

On October 1, 2025, ResMed (RMD) traded with a volume of $0.36 billion, ranking 349th in market activity. The stock closed 1.05% lower, signaling investor caution ahead of potential earnings reports and regulatory updates in the medical device sector.

Analysts noted that the decline may reflect broader market jitters over healthcare policy shifts and supply chain uncertainties. With the company’s recent product launches facing delayed approvals in key markets, short-term volatility remains elevated. However, long-term fundamentals remain intact, supported by aging demographics and rising sleep disorder diagnoses globally.

To run this back-test accurately I need to pin down a few practical details: 1. Universe • Which market should we scan each day for the “top 500 by trading volume” – all U.S. listed equities, a specific exchange (e.g. NYSE + NASDAQ), or another market? 2. Weighting & rebalancing • Should the 500 names be held equal-weight (i.e., 0.2 % per name) and rebalanced every day, or do you prefer a different weighting method? 3. Frictional costs • Do you want to include transaction costs (commission + slippage) given the daily turnover? Please let me know, and I’ll set the back-test up right away.